Skip to main content
Toggle navigation
Login
Search
Home
Tweets by IDWeek 2022
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Email
Tweet this
Print
Sailaja Puttagunta, MD
Chief Medical Officer
Iterum Therapeutics
Disclosure(s): Iterum Therapeutics: Stocks/Bonds
Poster(s):
227 - Impact of Asymptomatic Bacteriuria on Primary Efficacy Analyses in the Evaluation of Novel Antimicrobials for the Treatment of Patients with Urinary Tract Infection
Thursday, October 20, 2022
12:15 PM – 1:30 PM
US ET
1724 - Murine Efficacy Studies of Sulopenem Against
Bacillus anthracis
Saturday, October 22, 2022
12:15 PM – 1:30 PM
US ET
Email Sailaja
.png)
.png)
